Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
about
Increasing awareness of sex differences in airway diseasesAchromobacter xylosoxidans infection in cystic fibrosis siblings with different outcomes: Case reportsAn overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease.Update of literature from cystic fibrosis registries 2012-2015. Part 6: Epidemiology, nutrition and complications.17β-Estradiol inhibits phosphorylation of stromal interaction molecule 1 (STIM1) protein: implication for store-operated calcium entry and chronic lung diseases.Gender, Estrogen, and Obliterative Lesions in the Lung.Flagellin concentrations in expectorations from cystic fibrosis patientsRate of improvement of CF life expectancy exceeds that of general population--observational death registration study.Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis.Subcutaneous implant with etonogestrel (Implanon®) for catamenial exacerbations in a patient with cystic fibrosis: a case report.Non-genomic estrogen regulation of ion transport and airway surface liquid dynamics in cystic fibrosis bronchial epithelium.Gender differences in outcomes of patients with cystic fibrosisRecent advances in understanding and managing cystic fibrosis transmembrane conductance regulator dysfunction.Effects of puberty on cystic fibrosis related pulmonary exacerbations in women versus men.Innate Immune Signaling Activated by MDR Bacteria in the AirwayLung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation.Structural basis for KCNE3 modulation of potassium recycling in epitheliaGender differences in the development of uremic cardiomyopathy following partial nephrectomy: Role of progesterone.The cystic fibrosis gender gap: potential roles of estrogen.A systematic review of factors associated with health-related quality of life in adolescents and adults with cystic fibrosis.Association between serum 25-hydroxyvitamin D level and pulmonary exacerbations in cystic fibrosis.Management of pulmonary exacerbations in cystic fibrosis: still an unmet medical need in clinical practice.Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why?Microbiomes in respiratory health and disease: An Asia-Pacific perspective.17β-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism.Contraceptive practices and cervical screening in women with cystic fibrosis.Reduced bone volumetric density and weak correlation between infection and bone markers in cystic fibrosis adult patients.Role of sex steroid hormones in bacterial-host interactions.Depressive symptoms in spouses of older patients with severe sepsis, surrogate decision makers' interpretation of prognostic information, and effect of estrogen on pseudomonas in cystic fibrosis.Immune, inflammatory and infectious consequences of estrogen in women with cystic fibrosis.Morphological and genetic factors shape the microbiome of a seabird species (Oceanodroma leucorhoa) more than environmental and social factors.Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.Let's talk about sex: Behaviors, experience and health care utilization in young women with CF.Investigation of host and pathogen responses to estrogen in cystic fibrosis.Gender differences in bronchiectasis: a real issue?Sexual dimorphism in bacterial infections.
P2860
Q26775074-25FBACB6-4563-4D91-B295-C95F2FB6C682Q28818541-81F40395-06B2-426D-AF1A-03B36842825DQ30244524-D6320508-F407-4888-9393-4C2D8883A376Q30245013-3F5D8CC6-CB8F-451E-86BF-C6E22F826CFCQ30409431-6E0688AC-123C-488E-BD54-D34141F136C1Q33567156-282A88FB-FAA7-49A7-92D8-73B24A4B795DQ33768217-14841E1F-976F-405C-83D5-6573AF6FE0CCQ33818393-4B2E35D4-C2C8-4F45-809F-42E1C6076068Q34052878-B13DE501-A0AA-4C7F-825C-589EF0E9667FQ34469663-5E613F70-46C8-4B79-8B47-A0BAC07D5480Q35040980-76AB6F0F-2CD3-4727-9E75-394D570B9ADAQ35641585-CD2055FB-4A96-4E89-93C5-21A8A96DFB7BQ35659323-D4F69B32-27DC-482F-B8D9-991EC6D8782BQ35871921-88D3ABF8-55B4-46F9-A2C2-4302DFFBF84BQ36422470-B479F256-1573-43E9-BF3A-311E202C1D86Q37072994-94B3DFC1-C229-4622-90C0-3938B3A1979CQ37245582-D772ADDA-EAF5-4740-89DB-0C33DF66DE40Q37433869-511377E1-EC51-4FD7-B6C9-F2BA31768D29Q38171444-B447CE78-D835-4EA6-BC31-F3CF6C8B2969Q38340909-A7ED88A5-B6E8-4AFF-B3A9-CD41099956EFQ38346088-4284A69E-CCE1-41A3-8A71-C84392039784Q38360133-E3E7AC99-D7D7-48D3-8EDA-0C2F345A2013Q38552513-F44A59FE-3F19-4E76-B4A6-1FEBF04EF5DCQ39095070-853260E7-6991-49DA-8B38-95CB5879865FQ40103064-094D47BA-D058-4577-8AB9-989FA97F8254Q40566751-754067CF-866B-48BF-ACB0-40C6AC7F6B2BQ40680117-E3C6D818-3D5F-40A4-A8F6-FDAA2C7476D5Q41478569-BB1895A0-BC66-4D52-AAB2-514298C6BF26Q43729924-C4561B1F-E1BF-48BF-B5D8-63A385040F76Q44381085-78216EBF-AA9B-43E4-857A-EF2DC449A6FCQ45981743-4AADC0C9-2BB9-4FD1-8AC0-82E208B0CBDCQ46263483-D5B0B5FF-6BE7-49F9-85A0-A9D89C6625ABQ47658575-2E88F933-EBCB-4410-9B6B-3C77954235D7Q55136744-E2873CEB-B972-432F-A1D6-78D81F2ADCE3Q55299552-3EB24ACE-C4DA-4C8D-907E-FD10A051C044Q55431367-552B351A-8E6D-4788-BB5F-792925EDF06A
P2860
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
@en
type
label
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
@en
prefLabel
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
@en
P2093
P50
P356
P1476
Effect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosis.
@en
P2093
Cedric Gunaratnam
Noel G McElvaney
Shane J O'Neill
Sonya Cosgrove
P304
P356
10.1056/NEJMOA1106126
P407
P577
2012-05-20T00:00:00Z